Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI345
Clinical trial NCT05199519 · COMPLETED
Trial details
- NCT number
- NCT05199519
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2022-10-29
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.